01/09/2020 | News

Atriva Therapeutics to take part in three major conferences in San Francisco, USA, in the upcoming week

Tübingen (Germany), January 8, 2020 – Atriva Therapeutics GmbH, a clinical stage biopharmaceutical company pioneering the development of host-targeting antiviral therapies, announces its participation in three upcoming conferences in San Francisco, CA, USA, in January.

Dr. Rainer Lichtenberger, CEO, Dr. Christian Wallasch, COO, and Dr. Björn Cochlovius, VP Business Development, will represent the Company and be available for networking and one-on-one meetings at the following events:

 

Biotech ShowcaseTM

January 13th – 15th, 2020, Hilton San Francisco Union Square, San Francisco
Dr. Rainer Lichtenberger, CEO of Atriva, will give a Company Presentation on Jan. 13th, at 11:30 am, in room Franciscan D (Ballroom Level).
https://informaconnect.com/biotech-showcase/

 

RESI, Redefining Early Stage Investments
January 14th, 2020, Marines’ Memorial Club & Hotel, San Francisco
Dr. Rainer Lichtenberger, CEO of Atriva, will give a Company Presentation at 8:00 am, during the Track 4, Biotech Entrepreneur Pitch Session.
https://www.resiconference.com/

 

15th Non-Dilutive Funding Summit
January 15th, 2020, Marines’ Memorial Club & Hotel, San Francisco
https://www.freemindconsultants.com/15th-annual-non-dilutive-funding-summit-2/

Source:
https://www.atriva-therapeutics.com/news/91-news-jpmorgan2020